Financial Statements Comprehensive Operating Statement For the year ended 30 June 2018 Note 2018 2017 $ $ Income from transactions Contributions from Member Entities 2(a) 1,471,750 1,450,000 Contributions from Department of Health 2(a) 13,971,750 5,124,167 & Human Services Other income 2(a) 127,277 215,038 Interest income 2(b) 208,366 92,711 Total income from transactions 15,779,143 6,881,916 Expenses from transactions Project Expenditure Living with Cancer - (118,035) Leaders in Cancer Strategy - (21,190) Research Projects (615,044) (509,154) Education and Training Projects (254,316) (387,590) Clinical Research Focus Projects (358,425) (112,978) Other expenses Employee benefit expense 3(a) (2,527,980) (1,415,723) Supplies and services 3(b) (879,879) (620,826) Depreciation expense 3(c) (19,160) (13,671) Total expenses from transactions (4,654,804) (3,199,167) Net result from transactions (net operating balance) 11,124,339 3,682,749 Comprehensive result 11,124,339 3,682,749 This Comprehensive Operating Statement should be read in conjunction with the accompanying notes included on pages 12 to 33 of the full VCCC Annual Report 2017–18, available at www.viccompcancerctr.org 65